Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Puma Biotechnology
PBYI
|
+$276M |
| 2 |
Home Depot
HD
|
+$240M |
| 3 |
TE Connectivity
TEL
|
+$232M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$191M |
| 5 |
SHPG
Shire pic
SHPG
|
+$181M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$279M |
| 2 |
Meta Platforms (Facebook)
META
|
+$271M |
| 3 |
NVIDIA
NVDA
|
+$233M |
| 4 |
Cadence Design Systems
CDNS
|
+$222M |
| 5 |
CSX Corp
CSX
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.46% |
| 2 | Healthcare | 15.52% |
| 3 | Financials | 13.32% |
| 4 | Industrials | 12.73% |
| 5 | Consumer Discretionary | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPXL
726
DELISTED
Impax Laboratories, Inc.
IPXL
| $23.5M | 0.01% |
1,412,036
+4,488
| +0.3% | +$82.3K |
|
727
Manchester United
MANU
$3.91B
| $23.4M | 0.01% |
1,184,228
| – | – |
|
728
BP
BP
$113B
| $23.3M | 0.01% |
606,240
+42,310
| +8% | +$1.53M |
|
729
Invesco QQQ Trust
QQQ
$455B
| $23.3M | 0.01% |
149,555
-6,643
| -4% | -$1.01M |
|
730
TJX Companies
TJX
$170B
| $23.2M | 0.01% |
607,384
-100,160
| -14% | -$3.63M |
|
|
DEA
731
Easterly Government Properties
DEA
$1.18B
| $23M | 0.01% |
431,318
+1,340
| +0.3% | +$69.9K |
|
|
NUVA
732
DELISTED
NuVasive, Inc.
NUVA
| $23M | 0.01% |
392,470
+166,815
| +74% | +$9.46M |
|
733
Encompass Health
EHC
$11.2B
| $22.9M | 0.01% |
+583,678
| New | +$22.2M |
|
734
Dorman Products
DORM
$4.01B
| $22.9M | 0.01% |
375,226
+139,452
| +59% | +$9.45M |
|
735
Autodesk
ADSK
$44.3B
| $22.9M | 0.01% |
218,364
+153,813
| +238% | +$17.9M |
|
736
Newell Brands
NWL
$2.16B
| $22.7M | 0.01% |
735,250
+606,576
| +471% | +$20.9M |
|
737
WaFd
WAFD
$2.72B
| $22.7M | 0.01% |
662,174
-100
| -0% | -$3.43K |
|
738
Criteo
CRTO
$1.03B
| $22.5M | 0.01% |
864,418
-493,917
| -36% | -$17.7M |
|
739
Strategy Inc
MSTR
$33.5B
| $22.4M | 0.01% |
1,705,770
-223,390
| -12% | -$3M |
|
740
Ingles Markets
IMKTA
$1.63B
| $22.4M | 0.01% |
646,531
+182,287
| +39% | +$4.96M |
|
741
MetLife
MET
$61B
| $22.3M | 0.01% |
440,726
-239,956
| -35% | -$12.6M |
|
742
ResMed
RMD
$28.3B
| $22.2M | 0.01% |
262,320
+55,551
| +27% | +$4.59M |
|
743
Rhythm Pharmaceuticals
RYTM
$7B
| $21.9M | 0.01% |
+755,160
| New | +$20M |
|
744
Danaher
DHR
$135B
| $21.9M | 0.01% |
265,857
-283,094
| -52% | -$23M |
|
|
ELLI
745
DELISTED
Ellie Mae Inc
ELLI
| $21.8M | 0.01% |
244,105
+90,531
| +59% | +$8M |
|
746
Alcoa
AA
$11.7B
| $21.8M | 0.01% |
404,670
+92,850
| +30% | +$4.25M |
|
|
HTB
747
HomeTrust Bancshares
HTB
$818M
| $21.7M | 0.01% |
842,621
-15,518
| -2% | -$407K |
|
748
Sanofi
SNY
$104B
| $21.7M | 0.01% |
504,147
-17,404
| -3% | -$803K |
|
|
NOAH
749
Noah Holdings
NOAH
$588M
| $21.6M | 0.01% |
467,614
-35,000
| -7% | -$1.44M |
|
|
DCT
750
DELISTED
DCT Industrial Trust Inc.
DCT
| $21.6M | 0.01% |
368,027
+63,056
| +21% | +$3.73M |
|
Similar funds
Janus Henderson Group's Q4 2017 Portfolio in Review
As of Q4 2017, Janus Henderson Group held 1,379 positions worth $165B, up 5.4% from $156B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Janus Henderson Group's Q4 2017 filing shows 95 new, 535 increased, 621 reduced and 76 closed positions. Its largest new stake was Invitation Homes: 5,558,350 shares worth $131M. The largest sale was Lowe's Companies, an estimated $279M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q4 2017 buy was Invitation Homes: 5,558,350 shares worth $131M.
- Janus Henderson Group added most to Puma Biotechnology in Q4 2017, an estimated $276M increase.
- Janus Henderson Group's biggest Q4 2017 reduction was Lowe's Companies, cutting an estimated $279M.
- Janus Henderson Group fully exited CR Bard Inc. in Q4 2017, selling an estimated $124M.
- Janus Henderson Group's ten largest holdings make up 14% of its $165B portfolio in Q4 2017.
- Janus Henderson Group opened 95 new positions and closed 76 in Q4 2017.
- Janus Henderson Group's portfolio value rose 5.4% quarter-over-quarter to $165B.
Based on Janus Henderson Group's 13F filing for Q4 2017, filed 9 Feb 2018.